Analysed AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Surge in Monday Trading
15-06-2026
yahoo.com
Akari Therapeutics Completes Previously Announced PIPE, Strengthening Balance Sheet Ahead of Potential Key Clinical and Regulatory Milestones
29-06-2026
yahoo.com
Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board
07-07-2026
yahoo.com
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
21-07-2026
yahoo.com
Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity
22-07-2026
yahoo.com
Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation
04-08-2026
yahoo.com
Akari Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Progress of AKTX-101 Towards Phase 1 and Strategic Collaboration for Its ADC Payload Platform
13-08-2026
yahoo.com
Akari Therapeutics Builds Momentum for AKTX-101 with Compelling Urothelial Cancer Data Supporting Differentiated ADC Strategy
18-08-2026
yahoo.com
Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27-08-2026
yahoo.com
What is the current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?
The current price of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is $10.25.
AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is $-0.79.
AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) since the previous trading day is -7.1558%.
What is the most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?
The most recent average sentiment score for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)?
The most recent sentiment for AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ) is .
SEC-8K** Filing Available For AKARI THERAPEUTICS PLC-ADR (AKTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.